RBCGX
Price
$69.32
Change
+$0.52 (+0.76%)
Updated
Jun 2 closing price
Net Assets
69M
VIGRX
Price
$214.29
Change
+$1.43 (+0.67%)
Updated
Jun 2 closing price
Net Assets
269.26B
Interact to see
Advertisement

RBCGX vs VIGRX

Header iconRBCGX vs VIGRX Comparison
Open Charts RBCGX vs VIGRXBanner chart's image
Reynolds Blue Chip Growth
Price$69.32
Change+$0.52 (+0.76%)
VolumeN/A
Net Assets69M
Vanguard Growth Index Investor
Price$214.29
Change+$1.43 (+0.67%)
VolumeN/A
Net Assets269.26B
RBCGX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RBCGX vs. VIGRX commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RBCGX is a Buy and VIGRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 269B vs. RBCGX (69M). VIGRX pays higher dividends than RBCGX: VIGRX (0.35) vs RBCGX (0.00). RBCGX was incepted earlier than VIGRX: RBCGX (37 years) vs VIGRX (33 years). RBCGX (2.01) is less costly to investors than VIGRX (0.17). RBCGX is a more actively managed with annual turnover of: 269.00 vs. VIGRX (11.00). RBCGX has a lower initial minimum investment than VIGRX: RBCGX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 17.83 vs. RBCGX (11.33). VIGRX return over 5 years is better than : 109.40 vs. RBCGX (20.72).
RBCGXVIGRXRBCGX / VIGRX
Total Expense Ratio2.010.171,182%
Annual Report Gross Expense Ratio2.010.171,182%
Fund Existence37 years33 years-
Gain YTD2.0320.743273%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets69M269B0%
Annual Yield % from dividends0.000.35-
Returns for 1 year11.3317.8364%
Returns for 3 years36.8670.0653%
Returns for 5 years20.72109.4019%
Returns for 10 years12.38281.424%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMCB1.070.04
+4.35%
PharmaCyte Biotech
IKT2.050.04
+1.99%
Inhibikase Therapeutics
AC37.780.46
+1.23%
Associated Capital Group
GBDC15.14-0.07
-0.46%
Golub Capital BDC
CAG22.76-0.13
-0.57%
Conagra Brands